December 26, 2024
2024 AMDA/IPA International Pompe Patient and Scientific Conference Photo Gallery: May 5, 2024 Day 3 Photos
May 5, 2024: Day 3 – Conference Photos The final day of the 2024 AMDA/IPA International Pompe Patient & Scientific
December 26, 2024
2024 AMDA/IPA International Pompe Patient and Scientific Conference Photo Gallery: May 4, 2024 Day 2 Photos Part 1
May 4, 2024: Day 2 – Conference Photos: Part 1 Day 2 was a full day of sessions where we
December 26, 2024
2024 AMDA/IPA International Pompe Patient and Scientific Conference Photo Gallery: May 4, 2024 Day 2 Photos Part 2
May 4, 2024: Day 2 – Conference Photos: Part 2 Previous Post: Day 2 – Conference Photos: Part 1 Next
December 26, 2024
2024 AMDA/IPA International Pompe Patient and Scientific Conference Photo Gallery: May 3, 2024 Rodeo and Dinner Part 2
May 3, 2024: Day 1 – Welcome Dinner & Rodeo: Part 2 Previous Post: Day 1 – Welcome Dinner &
December 26, 2024
2024 AMDA/IPA International Pompe Patient and Scientific Conference Photo Gallery: May 3, 2024 Rodeo and Dinner Part 1
May 3, 2024: Day 1 – Welcome Dinner & Rodeo: Part 1 After the workshops, everyone was chartered over to
December 24, 2024
2024 AMDA/IPA International Pompe Patient and Scientific Conference Photo Gallery: May 3, 2024 – Day 1 Conference
May 3, 2024 – Day 1 – Conference Photos On May 3, 2024, patients, their family members, care givers, researchers,
The AMDA is partnering with Medlive to bring this exciting program to HCPs in the Pompe community. Join leading experts
August 1, 2024
2023 Helen Walker Grant Recipient
Project title: AutophagyThe cell's internal cleanup system that removes damaged or unneeded material. control of glycogenA stored form of sugar used for energy. in skeletal muscleMuscles that control movement and are commonly affected in Pompe disease. This year, the AMDA was fortunate to receive 13 grant applications focusing
We are excited to announce that the topic of our first “Talking With Your Pompe Peeps” session is “The Elementary School Experience:
University of California – San Francisco (UCSF) is excited to announce the rebranding of their phase 1 clinical trail of
